Check out your Company Bowl for anonymous work chats.
Have you seen the perks and benefits we offer to all Benchling employees? Read the latest article from Built In Boston to see what it’s like to be a part of the Benchling team!
The team at Benchling is excited to be one of Built In SF’s Featured Companies of the Month! Learn more about our mission, culture, and open roles in this new article!#Hiring #NowHiring
In this Forbes interview, co-founder and CEO Sajith Wickramasekara shares our origin story and the core strategies that continue to fuel Benchling's growth today.
Benchling has acquired Overwatch Research, a Belfast-based startup creating software to accelerate in vivo research. Through this acquisition, Benchling will create the industry’s first comprehensive, cloud-native in vivo solution, chelping customers accelerate the time to bring products to the clinic.
Benchling expands its executive team and Board of Directors with Paul Robson as the new President of Field Operations, and Elena Donio joining the board. These seasoned leaders will play instrumental roles as Benchling grows rapidly to accelerate biotech R&D across global industries including biopharma, agriculture, materials, and many more.
We announced our Series F funding, which we’ll use to continue developing modern software for modern science. Our customers are tackling humanity's most pressing challenges as they develop new medicines, crops, and other breakthrough products faster than ever.
Benchling is excited to welcome Lindsey Irvine to the leadership team as Chief Marketing Officer! Irvine joins Benchling from Salesforce where she spent eight years, most recently as global CMO of MuleSoft.
John Cumbers, Senior Contributor for Forbes recently interviewed Benchling's CEO, Saji Wickramasekara, to discuss how Benchling is enhancing humanity's ability to fight new diseases, and what this means for the future of the RNA research & development industry. Visit the article to learn more.
This week, we spoke with our teammate Madelyn to learn about how she is helping the next generation of scientists make breakthrough discoveries faster than ever before. In our talk, Madelyn walked us through her journey going from bench scientist to becoming an integral part of Benchling’s Customer Experience team, and shared her personal experience of life at Benchling.
We are thrilled to announce our Series D funding and are honored to be named by Forbes as one of the next billion-dollar startups. As the world looks to scientists for hope, we remain committed to our original mission: To build tools that accelerate life-changing work.
